LCM
PHAS

Laurion Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Laurion Capital Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-54,072
Closed -$167K – 967
2018
Q4 		$167K Buy
+54,072
New +$167K ﹤0.01% 605